Welcome to our dedicated page for CARECLOUD news (Ticker: CCLDO), a resource for investors and traders seeking the latest updates and insights on CARECLOUD stock.
CareCloud Inc (CCLDO) delivers cloud-based healthcare technology solutions that power high-growth medical practices through innovative EHR systems, practice management tools, and telehealth platforms. This dedicated news hub provides investors and industry professionals with timely updates on the company’s operational milestones, financial performance, and strategic initiatives.
Access authoritative reporting on CareCloud’s latest developments including quarterly earnings, product enhancements, leadership changes, and strategic partnerships. Our curated collection ensures you stay informed about critical updates affecting this healthcare IT innovator’s market position and service offerings.
Key focus areas include advancements in CareCloud’s revenue cycle management solutions, expansions of its telehealth capabilities, and developments in healthcare data analytics. All content is verified through primary sources to maintain accuracy and compliance with financial disclosure standards.
Bookmark this page for streamlined access to CareCloud’s official communications and third-party analyses. Regularly updated to reflect new developments in cloud-based healthcare technology and corporate strategy.
CareCloud (Nasdaq: CCLD) reported strong Q2 2025 financial results, marking its first quarter of positive GAAP EPS since going public in 2014. The company achieved GAAP net income of $2.9 million, a 73% increase from Q2 2024, and revenue of $27.4 million.
Key highlights include the launch of their AI Center of Excellence, scaling to 500 team members by year-end, and the completion of two acquisitions in 2025. The company reaffirmed its 2025 guidance, projecting revenue of $111-114 million, Adjusted EBITDA of $26-28 million, and GAAP EPS of $0.10-0.13.
Year-to-date performance showed strong growth with GAAP net income up 238% to $4.9 million and free cash flow increasing 85% to $9.0 million compared to the same period last year.
CareCloud (Nasdaq: CCLD) has achieved ONC Health IT Certification for its electronic health record (EHR) platform specifically designed for Critical Access Hospitals (CAHs). This certification, granted on August 1, 2025, enables CareCloud to enter the $1.5 billion+ inpatient EHR market serving over 1,300 CAHs.
The company's AI-powered, cloud-based platform addresses the unique needs of rural hospitals, offering certified compliance, support for various workflows, and built-in AI tools. According to Black Book Research, over 50% of rural and CAHs plan to replace their legacy EHR systems by 2026, presenting a significant market opportunity for CareCloud's modern solution.
CareCloud (Nasdaq: CCLD), a healthcare technology and generative AI solutions provider, has announced monthly cash dividend payments for its Series A and Series B Preferred Stock for July, August, and September 2025.
The company will pay $0.18229 per share monthly dividend for both Series A and B Preferred Stock. Series A holders will receive an additional $0.04688 per share payment due to historical rate adjustments. Both series carry an 8.75% annual dividend rate on the $25.00 per share liquidation preference. Dividends will be paid on August 15, September 15, and October 15, 2025.
Series A holders converted before March 6, 2025, are not eligible for these payments as they have already received their dividends in shares.CareCloud (Nasdaq: CCLD) has launched an AI-driven, fully integrated dermatology Electronic Health Record (EHR) system targeting the $9 billion U.S. dermatology services market. The cloud-based platform combines AI-powered documentation, advanced image management, and seamless integration with practice management, revenue cycle management (RCM), and telehealth services.
The comprehensive solution features AI-powered charting, customizable templates, advanced image management, integrated telehealth capabilities, optimized billing, and seamless interoperability with labs and pharmacies. The platform aims to streamline clinical workflows, enhance patient engagement, and improve financial outcomes for dermatology practices of all sizes.
CareCloud (Nasdaq: CCLD), a provider of AI-powered healthcare technology and revenue cycle management solutions, has scheduled its Q2 2025 earnings release for August 5, 2025, before market opening.
The company will host a conference call for investors at 8:30 a.m. Eastern Time on the same day. Investors can access the live webcast and presentation slides at ir.carecloud.com/events, or join via audio-only option by dialing 201-389-0920.
CareCloud (Nasdaq: CCLD), a healthcare technology and revenue cycle management solutions provider, reported a remarkable 70% stock price increase in Q2 2025, emerging as one of the top gainers in the Russell Microcap® Index. The company was officially added to the index on June 30, 2025.
Key developments include the launch of an AI Center of Excellence, resumed M&A activities, conversion of 3.5 million Series A Preferred shares into Common Stock, and a healthy cash position of over $10 million. The company's strategic focus on AI innovation and intelligent health solutions positions it for continued growth in 2025.
CareCloud (Nasdaq: CCLD), an AI-driven healthcare technology solutions provider, has been added to the Russell Microcap® Index effective June 30, 2025. The company experienced significant growth with its stock price rising approximately 70% during Q2 2025.
Notable achievements include launching an AI Center of Excellence, resuming acquisition activities, and maintaining a strong cash position of $10 million at Q2 end. Additionally, approximately 3.5 million shares of Series A Preferred Stock were converted to Common Stock on March 6, 2025.
CareCloud (Nasdaq: CCLD), an AI-driven healthcare technology solutions provider, has announced reaching a significant milestone with a public float of $85.1 million as of June 30, 2025. This achievement triggers new SEC compliance requirements, specifically the need for auditor attestation of Internal Control over Financial Reporting (ICFR) under Sarbanes-Oxley Act Section 404(b).
The Company's current audit firm has indicated it lacks capacity to perform the required ICFR attestation. As SEC regulations mandate the same firm conduct both financial statement audit and ICFR attestation, CareCloud has initiated a search for a new audit firm to handle these responsibilities for fiscal year 2025.
CareCloud (Nasdaq: CCLD), an AI-driven healthcare technology solutions provider, announced that its current independent registered public accounting firm may resign if the company requires an Internal Control over Financial Reporting (ICFR) attestation for fiscal year 2025.
The requirement for ICFR attestation will be determined by CareCloud's public float as of June 30, 2025. If it reaches or exceeds $75 million, the company will be classified as an accelerated filer, necessitating the attestation under Section 404(b) of the Sarbanes-Oxley Act. The current audit firm has stated it lacks capacity for ICFR attestation, which would require CareCloud to engage a new accounting firm as SEC rules mandate the same firm conduct both financial statement audit and ICFR attestation.
FAQ
What is the current stock price of CARECLOUD (CCLDO)?
